Asthma control is reached in a large majority of asthmatics treated with omalizumab. An Italian observational study

F. Novelli, G. Lenzini, M. Latorre, L. Malagrinò, F. L. Dente, P. L. Paggiaro (Pisa, Italy)

Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Session: Disease control and quality of life in airway diseases
Session type: Thematic Poster Session
Number: 811
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Novelli, G. Lenzini, M. Latorre, L. Malagrinò, F. L. Dente, P. L. Paggiaro (Pisa, Italy). Asthma control is reached in a large majority of asthmatics treated with omalizumab. An Italian observational study. Eur Respir J 2013; 42: Suppl. 57, 811

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Interim analysis of a prospective study investigating oral corticosteroid (OCS) use in omalizumab treated severe allergic asthma patients: APEX II study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Tiotropium for uncontrolled asthma (a meta-analysis)
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013



Ketamine versus aminophylline for status asthmatic in children: A randomized, controlled trial
Source: International Congress 2014 – Lung disease in neonates and beyond
Year: 2014

P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016

APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015


The elderly subjects with asthma (ELSA) study. Asthma in subjects ≥65 yrs and its overlap with COPD
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013

Asthma clusters in a real asthmatic population, treated in secondary medical care
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014

A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

First clinical trial of a new IgE-adsorber in allergic asthma
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015

Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of asthma . A comparative study
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014


A population-based study of animal component sensitization, asthma and rhinitis in school children
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015

Five-year clinical study of children with atopic asthma
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014

Work related symptoms of adult patients with asthma: A multicenter, national, questionnaire based study
Source: International Congress 2015 – Work, environment and the epidemiology of asthma
Year: 2015

Risk factors for poor asthma control in asthmatic children
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014


Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013

Introduction of new asthma guidelines did not improve asthma control in a Dutch paediatric population
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014


Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


The control of asthma in real life: Baseline evaluation of a long-term study
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016